금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
US Dollar Index eases from tops, back to 101.30 ahead of Fed
The Greenback, when tracked by the US Dollar Index (DXY), abandons the area of monthly peaks and rec...
Euro skyrockets amid softer US confidence
EUR/USD trades higher near the 1.1400 area on Tuesday, gaining around 0.3% as the US Dollar (USD) we...
Oil Prices Retreat, But the Strait of Hormuz Remains the Wild Card
Trump's latest comments cooled oil prices, but talks over ending the Strait of Hormuz blockade could...
2 Reasons to Like RBA and 1 to Stay Skeptical
RB Global trades at $113.92 per share and has stayed right on track with the overall market, gaining 8.8% over the last six months. At the same time, the S&P 500 has returned 6.1%.
Amphenol top pick, cautious near-term stance on TE Connectivity and Sensata: Evercore
US Crude Output Sets New Monthly Production Record
According to monthly data released Tuesday by the U.S. Energy Information Administration (EIA), U.S. crude oil production climbed to a record 13.934 million barrels per day (bpd) in April—the highest ...
3 Reasons to Avoid SBCF and 1 Stock to Buy Instead
Seacoast Banking trades at $33.10 and has moved in lockstep with the market. Its shares have returned 5.4% over the last six months while the S&P 500 has gained 6.1%.
Owens Corning upped at Evercore ISI after report of Carlisle bids
Volkswagen potentially could boost its dividend payout after asset sale
Honeywell Aerospace rated Neutral in new coverage by BNP Paribas
Charter Communications seen facing tougher Q2 comparisons, SpaceX deal faces hurdles—Citi Research
Wall Street’s Blue-Chip Index Just Cast Out Verizon for a Higher-Risk AI Growth Machine
Alphabet (NASDAQ:GOOGL) and Verizon (NYSE:VZ) just delivered Q1 2026 results that reveal why S&P Dow Jones Indices swapped the telecom giant out of the Dow for the search and cloud heavyweight. Alphab ...
3 Reasons CVBF is Risky and 1 Stock to Buy Instead
CVB Financial has had an impressive run over the past six months as its shares have beaten the S&P 500 by 13%. The stock now trades at $22.40, marking a 19.1% gain. This performance may have investors ...
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TMDX is advancing its OCS platform and transplant ecosystem, but margin pressure from expansion investments remains a key concern.
Wall Street moved higher as tech continues to rebound